If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,251.00    9.00 (0.72%)
Bid:
1,249.00
Ask:
1,251.00
Spread: 2.00 (0.16%)
Market Cap: £864.65m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Total Voting Rights

28 Feb 2025 09:57

RNS Number : 8994Y
CVS Group plc
28 February 2025
 

28 February 2025

CVS Group plc

("CVS" or the "Company")

Total Voting Rights

CVS, the UK-listed veterinary group and a leading provider of veterinary services, announces that, as of 28 February 2025, the Company's total issued share capital consists of 71,740,184 Ordinary Shares of 0.2p each with each one carrying one voting right. The Company holds no Ordinary Shares in treasury and the total number of voting rights is therefore 71,740,184.

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts:

Contacts

CVS Group plc via Camarco

Richard Fairman, Chief Executive Officer

Robin Alfonso, Chief Financial Officer

Paul Higgs, Chief Veterinary Officer

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)   +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker)  +44 (0)20 3207 7800

Toby Flaux / Michael Burke / James Thompson / Milo Bonser

 

Camarco (Financial PR)

Ginny Pulbrook +44 (0)20 3757 4980

Tilly Butcher

Letaba Rimell About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK, and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.460 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices) and an online retail business ("Animed Direct").

 

 The Group employs c.9,000 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRPKFBPCBKKNBB
Date   Source Headline
13th Dec 20217:00 amRNSPDMR/PCA Dealings
7th Dec 202111:06 amRNSPDMR/PCA Dealings
30th Nov 20217:00 amRNSExercise of Options and Total Voting Rights
26th Nov 20215:31 pmRNSHolding(s) in Company
26th Nov 20215:24 pmRNSHolding(s) in Company
26th Nov 20218:16 amRNSGrant of Options & PDMR Dealing
26th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20213:09 pmRNSResult of AGM
24th Nov 20217:00 amRNSAGM Statement and Trading Update
19th Nov 20214:26 pmRNSHolding(s) in Company
10th Nov 202111:17 amRNSHolding(s) in Company
3rd Nov 20212:30 pmRNSPCA Shareholding
1st Nov 20218:00 amRNSHolding(s) in Company
29th Oct 202110:17 amRNSPosting of Annual Report & Notice of AGM
29th Oct 20217:00 amRNSExercise of Options and Total Voting Rights
13th Oct 20216:01 pmRNSExercise of Options, PDMR Dealing and TVR
7th Oct 20211:52 pmRNSHolding(s) in Company
7th Oct 20217:00 amRNSLong Term Incentive Plan Awards & PDMR Dealing
30th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
29th Sep 20215:28 pmRNSHolding(s) in Company
28th Sep 20217:54 amRNSHolding(s) in Company
23rd Sep 20217:00 amRNSBoard Changes
23rd Sep 20217:00 amRNSFinal results for the year ended 30 June 2021
13th Sep 20211:50 pmRNSHolding(s) in Company
31st Aug 20217:00 amRNSExercise of Options and Total Voting Rights
27th Aug 20215:34 pmRNSHolding(s) in Company
26th Aug 20218:48 amRNSBlock Listing Application
24th Aug 20214:10 pmRNSHolding(s) in Company
20th Aug 20212:09 pmRNSHolding(s) in Company
20th Aug 20212:07 pmRNSHolding(s) in Company
30th Jul 202112:00 pmRNSExercise of Options and Total Voting Rights
29th Jul 20214:14 pmRNSHolding(s) in Company
20th Jul 20217:00 amRNSTrading Update
13th Jul 202112:40 pmRNSBlock Listing Interim Review and TVR Update
30th Jun 20217:00 amRNSExercise of Options and Total Voting Rights
28th May 202112:00 pmRNSExercise of Options and Total Voting Rights
13th May 20218:30 amRNSShareholder Consultation regarding 2020 AGM
30th Apr 202112:00 pmRNSExercise of Options and Total Voting Rights
30th Apr 20217:00 amRNSTrading Update
7th Apr 20217:00 amRNSDirector/PDMR Shareholding
31st Mar 20217:00 amRNSExercise of Options and Total Voting Rights
30th Mar 20219:06 amRNSDirector/PDMR and PCA Shareholding
25th Mar 20217:00 amRNSInterim Results
3rd Mar 20217:30 amRNSHolding(s) in Company
26th Feb 202112:00 pmRNSExercise of Options and Total Voting Rights
5th Feb 20214:30 pmRNSHolding(s) in Company
29th Jan 202112:00 pmRNSExercise of Options
29th Jan 20217:00 amRNSTrading Update
6th Jan 20219:30 amRNSBlock Listing Application
5th Jan 20217:00 amRNSLong Term Incentive Plan Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.